Zydus Lifesci.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE010B01027
  • NSEID: ZYDUSLIFE
  • BSEID: 532321
INR
1,195.05
-4.95 (-0.41%)
BSENSE

Nov 20

BSE+NSE Vol: 7.94 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 290229,
    "name": "Zydus Lifesci.",
    "stock_name": "Zydus Lifesci.",
    "full_name": "Zydus Lifesciences Ltd",
    "name_url": "stocks-analysis/zydus-lifesci",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,195.05",
    "chg": -4.95,
    "chgp": "-0.41%",
    "dir": -1,
    "prev_price": "1,200.00",
    "mcapval": "119,930.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532321,
    "symbol": "ZYDUSLIFE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE010B01027",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "7.94 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/zydus-lifesci-290229-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Zydus Lifesciences Gains 0.34%: 4 Key Factors Driving This Week’s Mixed Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/zydus-lifesciences-gains-034-4-key-factors-driving-this-weeks-mixed-momentum-4271206",
        "imagepath": "",
        "date": "2026-11-22 11:00:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Nov:</strong> Technical momentum shifts amid mixed indicator signals</p>\n                    <p><strong>18 Nov:</strong> Significant open interest surge in derivatives</p>\n                    <p><strong>18 Nov:</strong> Technical momentum upgrades to bullish trend</p>\n                    <p><strong>18 Nov:</strong> Valuation grade upgraded to attractive</p>\n                    <p><strong>20 Nov:</strong> Week closes at ₹1,195.05 (+0.34%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹1,189.00</div></div>\n                    <div class=\"stat-item\"><div ..."
      },
      {
        "title": "Zydus Lifesciences Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/zydus-lifesciences-ltd-is-rated-hold-by-marketsmojo-4269088",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/ZydusLifescienc_mojoScore_4269088.png",
        "date": "2026-11-20 10:11:27",
        "description": "Zydus Lifesciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 November 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Zydus Lifesciences Sees Significant Open Interest Surge Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/zydus-lifesciences-sees-significant-open-interest-surge-amid-mixed-market-signals-4267226",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/ZydusLifescienc_oi_spurts_by_underlying_4267226.png",
        "date": "2026-11-18 15:00:12",
        "description": "Zydus Lifesciences Ltd has witnessed a notable 10.65% increase in open interest in its derivatives segment, signalling heightened market activity despite a marginal decline in its share price. This surge in open interest, coupled with volume and positioning data, offers valuable insights into investor sentiment and potential directional bets in the pharmaceutical mid-cap stock."
      },
      {
        "title": "Zydus Lifesciences Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/zydus-lifesciences-ltd-valuation-shifts-signal-renewed-price-attractiveness-4265821",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/ZydusLifescienc_valuationdot_4265821.png",
        "date": "2026-11-18 08:01:10",
        "description": "Zydus Lifesciences Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating, signalling improved price appeal for investors. This change comes amid a backdrop of mixed valuations across the Pharmaceuticals & Biotechnology sector, with Zydus now standing out for its relative affordability and solid financial metrics."
      },
      {
        "title": "Zydus Lifesciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/zydus-lifesciences-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4265817",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/ZydusLifescienc_technicaldot_4265817.png",
        "date": "2026-11-18 08:01:07",
        "description": "Zydus Lifesciences Ltd has exhibited a notable shift in technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by a combination of moving averages, MACD, and Bollinger Bands signals, suggesting a strengthening price momentum amid a robust market backdrop."
      },
      {
        "title": "Zydus Lifesciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/zydus-lifesciences-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4262940",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/ZydusLifescienc_technicaldot_4262940.png",
        "date": "2026-11-16 08:00:53",
        "description": "Zydus Lifesciences Ltd has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of early November 2026. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the pharmaceutical and biotechnology company continues to demonstrate resilience with a year-to-date return of 30.2%, significantly outperforming the Sensex’s negative 4.3% over the same period."
      },
      {
        "title": "Zydus Lifesciences Ltd Technical Momentum Shifts to Bullish Amid Strong Long-Term Returns",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/zydus-lifesciences-ltd-technical-momentum-shifts-to-bullish-amid-strong-long-term-returns-4259932",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/ZydusLifescienc_technicaldot_4259932.png",
        "date": "2026-11-13 08:01:25",
        "description": "Zydus Lifesciences Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is supported by a confluence of technical indicators including MACD, moving averages, and Bollinger Bands, suggesting a strengthening price momentum amid a mid-cap pharmaceutical sector backdrop."
      },
      {
        "title": "Zydus Lifesciences Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/zydus-lifesciences-ltd-is-rated-hold-by-marketsmojo-4256755",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/ZydusLifescienc_mojoScore_4256755.png",
        "date": "2026-11-09 10:10:22",
        "description": "Zydus Lifesciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 November 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Zydus Lifesciences Falls 3.94%: 5 Key Factors Behind the Weekly Decline",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/zydus-lifesciences-falls-394-5-key-factors-behind-the-weekly-decline-4256107",
        "imagepath": "",
        "date": "2026-11-08 10:01:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Nov:</strong> New 52-week high at Rs.1,259.1</p>\n                    <p><strong>3 Nov:</strong> Further 52-week high at Rs.1,264.2 with bullish technical momentum</p>\n                    <p><strong>4 Nov:</strong> New 52-week high at Rs.1,264.4 followed by sharp open interest surge</p>\n                    <p><strong>5 Nov:</strong> Mixed Q3 results with strong revenue growth but profitability challenges</p>\n                    <p><strong>6 Nov:</strong> Week closes at Rs.1,195.00, down 0.12% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,..."
      }
    ],
    "total": 187,
    "sid": "290229",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/zydus-lifesciences-290229"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "14-Nov-2026",
      "details": "Press Release",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Updates on Joint Venture",
      "datetime": "12-Nov-2026",
      "details": "Completion of transaction",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "07-Nov-2026",
      "details": "Transcript of the post results earnings call held on November 4 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has declared <strong>100%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has announced <strong>1:5</strong> stock split, ex-date: 06 Oct 15",
          "dt": "2015-10-06",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 05 Apr 10",
          "dt": "2010-04-05",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Press Release / Media Release

14-Nov-2026 | Source : BSE

Press Release

Announcement under Regulation 30 (LODR)-Updates on Joint Venture

12-Nov-2026 | Source : BSE

Completion of transaction

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

07-Nov-2026 | Source : BSE

Transcript of the post results earnings call held on November 4 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Zydus Lifesciences Ltd has declared 100% dividend, ex-date: 24 Jul 26

stock-summary
SPLITS

Zydus Lifesciences Ltd has announced 1:5 stock split, ex-date: 06 Oct 15

stock-summary
BONUS

Zydus Lifesciences Ltd has announced 1:2 bonus issue, ex-date: 05 Apr 10

stock-summary
RIGHTS

No Rights history available